← Back to Analyst Consensus 
ANVS Buy
Annovis Bio, Inc.
Current Price —
Implied Upside —
Analysts 10
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 10, 2026 (15 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 28, 2026 | Roth Capital | maintain | Buy → Buy | — | 53% |
| Aug 18, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Jul 8, 2026 | Roth Capital | initiate | — → Buy | — | 53% |
| Apr 14, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Sep 30, 2025 | Canaccord Genuity | maintain | Buy → Buy | $17 | 48% |
| Sep 3, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $10 | 44% |
| Jun 9, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $12 | 44% |
| May 15, 2025 | Canaccord Genuity | maintain | Buy → Buy | $17 | 48% |
| Feb 10, 2025 | D. Boral Capital | downgrade | Buy → Hold | $0 | 34% |
| Nov 11, 2024 | D. Boral Capital | maintain | Buy → Buy | $21 | 34% |
| Nov 11, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $30 | 44% |
| Oct 25, 2024 | Maxim Group | upgrade | Hold → Buy | $25 | 42% |
| Aug 15, 2024 | EF Hutton | maintain | Buy → Buy | $21 | 30% |
| Aug 15, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $30 | 44% |
| Aug 13, 2024 | EF Hutton | initiate | — → Buy | $21 | 30% |
| Jul 17, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $30 | 44% |
| Jul 11, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $30 | 44% |
| Jul 2, 2024 | Rodman & Renshaw | reiterate | Buy → Buy | $67 | 40% |
| Jun 12, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $23 | 44% |
| Jun 4, 2024 | Rodman & Renshaw | initiate | — → Buy | $67 | 40% |
| May 13, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $23 | 44% |
| Apr 30, 2024 | Canaccord Genuity | maintain | Buy → Buy | $26 | 48% |
| Apr 30, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $30 | 44% |
| Apr 2, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $30 | 44% |
| Mar 21, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $30 | 44% |
| Feb 28, 2024 | Brookline Capital | downgrade | Buy → Hold | $9 | 38% |
| Dec 29, 2023 | Canaccord Genuity | initiate | — → Buy | $36 | 48% |
| Nov 28, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $30 | 44% |
| Nov 13, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $30 | 44% |
| Nov 10, 2023 | Brookline Capital | initiate | — → Buy | $35 | 38% |
| Aug 15, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $40 | 44% |
| Jun 28, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $40 | 44% |
| Jun 9, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $40 | 44% |
| Apr 21, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $40 | 44% |
| Feb 8, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $40 | 44% |
| Sep 8, 2022 | HC Wainwright & Co. | initiate | — → Buy | $40 | 44% |
| May 2, 2022 | Ladenburg Thalmann | initiate | — → Buy | $37 | 45% |
Price Target Trend
Apr 3, 2026 Oct 26, 2026
EPS Estimates
+1y —
+1q —
0q —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days